explorer. Forget the investment folk and their recommendations. As people repeatedly state, how often have they been right + They quite often have agendas for spin.
Ditto AS, keep a finger on the pulse of the industry and you will find a whole different range of literature and perspectives. That lay of the land is my puzzle. All the AS/UNS spin, financial gurus all jumping on/off...if their info is a square then it wont fit my puzzle that needs a small cirle.
If they start telling me its a big circle, then at least its the right shape and with some time the sizes may come to align.
When we were in the 30s a few months back I commented that sentiment is allowed to run riot with this stock.
We have had good news lately....hell even I am starting to prick my ears up a little based on my stoooopid puzzle analogy above. But most seem to think we are dead. The sensible approach was the company had a good chance of being profitable in 2016.
The Sanofi deal being what it is and a competitor getting a 20million up front payment for one of their devices that is similar/same as our Bolus injector...well that 2016 assessment could be closer to 2015.
We are in reasonable shape that with say 5million a quarter in revenue that the remaining ATM will see us through to end of next year.
Any growth or expansion of production costs seems to be covered by fiannce/leasing. Even if they had cash, you wuodlnt tie it up in capital equipment so...
NOT in a great place...but UNS are in a far better place than in July.
And thats a mug sook like me who is basing it on very tangible information in the market...not aspirations of CEOs/Salesman...investment gurus who are never right etc
Add to My Watchlist
What is My Watchlist?